DIURIL (chlorothiazide) by Teva is clinical pharmacology the mechanism of the antihypertensive effect of thiazides is unknown. Approved for hypertension, essential hypertension. First approved in 1958.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
DIURIL (chlorothiazide) is an oral thiazide diuretic approved in 1958 that reduces blood pressure by increasing sodium and chloride excretion in the distal renal tubule. It treats hypertension and is indicated across multiple cardiometabolic conditions including diabetes, chronic kidney disease, and coronary artery disease. The mechanism of antihypertensive action remains incompletely understood, though diuresis begins within 2 hours and peaks at 4 hours with a 6-12 hour duration.
Minimal commercial momentum; small Part D footprint (233 claims in 2023) indicates generic commoditization and reduced brand team support.
CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. DIURIL does not usually affect normal blood pressure. DIURIL affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in…
Worked on DIURIL at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide
Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DIURIL offers minimal career growth as a legacy generic with zero linked job openings and declining commercial relevance. Roles available are primarily defensive (cost management, compliance, safety monitoring) rather than growth-oriented, positioning this product for pharmaceutical professionals seeking stable but non-advancing career trajectories.